
Profile
General Information
Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.
Approval Date: 1998-01-01
Company Name: Watson Pharmaceuticals